Cardiac Oncology – Anna Gams

Atrial fibrillation (AF) is commonly observed in cancer patients who have undergone a targeted therapy and/or surgery. Cancer progression causes inflammation and chemotherapeutic agents are known to exhibit cardiotoxic effects. Mechanisms that trigger AF due to inflammation or chemotherapy remain under-explored. In this project we are studying cancer related cardiac complications using mouse model of pancreatic cancer.